Advanced search
Start date
Betweenand

Functional Role of Arginase II (ARG2) in the Pathogenesis of Thyroid Tumors

Grant number: 09/11257-7
Support Opportunities:Regular Research Grants
Start date: December 01, 2009
End date: November 30, 2011
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal Investigator:Janete Maria Cerutti
Grantee:Janete Maria Cerutti
Host Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil
Articles published in Agência FAPESP Newsletter about the research grant:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications (6)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
SOUSA, MARIA SHARMILA A.; LATINI, FLAVIA R. M.; MONTEIRO, HUGO P.; CERUTTI, JANETE M.. Arginase 2 and nitric oxide synthase: Pathways associated with the pathogenesis of thyroid tumors. Free Radical Biology and Medicine, v. 49, n. 6, p. 997-1007, . (05/60330-8, 09/11257-7)
CAMACHO, CLEBER P.; LINDSEY, SUSAN C.; MELO, MARIA CLARA C.; YANG, JI H.; GERMANO-NETO, FAUSTO; VALENTE, FLAVIA DE O. F.; LIMA, THIAGO R. N.; BISCOLLA, ROSA PAULA M.; VIEIRA, JOSE G. H.; CERUTTI, JANETE M.; et al. Measurement of Calcitonin and Calcitonin Gene-Related Peptide mRNA Refines the Management of Patients with Medullary Thyroid Cancer and May Replace Calcitonin-Stimulation Tests. THYROID, v. 23, n. 3, p. 308-316, . (11/20747-8, 06/60402-1, 09/11257-7)
CERUTTI, JANETE M.. Employing Genetic Markers to Improve Diagnosis of Thyroid Tumor Fine Needle Biopsy. CURRENT GENOMICS, v. 12, n. 8, p. 589-596, . (05/60330-8, 09/11257-7)
OLIVEIRA, MARIANA N. L.; HEMERLY, JEFFERSON P.; BASTOS, ANDRE U.; TAMANAHA, ROSANA; LATINI, FLAVIA R. M.; CAMACHO, CLEBER P.; IMPELLIZZERI, ANELISE; MACIEL, RUI M. B.; CERUTTI, JANETE M.. The RET p.G533C Mutation Confers Predisposition to Multiple Endocrine Neoplasia Type 2A in a Brazilian Kindred and Is Able to Induce a Malignant Phenotype In Vitro and In Vivo. THYROID, v. 21, n. 9, p. 975-985, . (05/60330-8, 06/60402-1, 09/11257-7)
VALENTE, F. O. F.; DA SILVA, M. R. DIAS; CAMACHO, C. P.; KUNII, I. S.; BASTOS, A. U.; DA FONSECA, C. C. N.; SIMIAO, H. P. C.; TAMANAHA, R.; MACIEL, R. M. B.; CERUTTI, J. M.. Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype- phenotype correlation: An appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, v. 36, n. 11, p. 975-981, . (09/11257-7)
HEMERLY, JEFFERSON PESSOA; BASTOS, ANDRE UCHIMURA; CERUTTI, JANETE M.. Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomas. EUROPEAN JOURNAL OF ENDOCRINOLOGY, v. 163, n. 5, p. 747-755, . (05/60330-8, 09/11257-7)